235 related articles for article (PubMed ID: 20064476)
1. Vaccine adjuvants: a priority for vaccine research.
Harandi AM; Medaglini D; Shattock RJ;
Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
[TBL] [Abstract][Full Text] [Related]
2. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
Ross AL; Bråve A; Scarlatti G; Manrique A; Buonaguro L
Lancet Infect Dis; 2010 May; 10(5):305-16. PubMed ID: 20417413
[TBL] [Abstract][Full Text] [Related]
3. Vaccine adjuvants: scientific challenges and strategic initiatives.
Harandi AM; Davies G; Olesen OF
Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
[TBL] [Abstract][Full Text] [Related]
4. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
5. Advances and challenges in mucosal adjuvant technology.
Newsted D; Fallahi F; Golshani A; Azizi A
Vaccine; 2015 May; 33(21):2399-405. PubMed ID: 25865473
[TBL] [Abstract][Full Text] [Related]
6. Are we entering a new age for human vaccine adjuvants?
O'Hagan DT; Fox CB
Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunity on the banks of the Duoro.
Lavelle EC; Thanavala Y; Ogra P
Hum Vaccin; 2009 May; 5(5):281-3. PubMed ID: 19229136
[TBL] [Abstract][Full Text] [Related]
8. New developments in nanoparticle-based vaccination.
Riedmann EM
Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
[No Abstract] [Full Text] [Related]
9. Optimizing vaccine development.
Hoft DF; Brusic V; Sakala IG
Cell Microbiol; 2011 Jul; 13(7):934-42. PubMed ID: 21631691
[TBL] [Abstract][Full Text] [Related]
10. Vaccine adjuvants: smart components to boost the immune system.
Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
[TBL] [Abstract][Full Text] [Related]
11. IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.
Seemann S; Dodet B
Vaccine; 2011 Apr; 29(17):3340. PubMed ID: 21335035
[No Abstract] [Full Text] [Related]
12. Trends in vaccine adjuvants.
Schijns VE; Lavelle EC
Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
[TBL] [Abstract][Full Text] [Related]
13. Vaccine adjuvants: key tools for innovative vaccine design.
Riese P; Schulze K; Ebensen T; Prochnow B; Guzmán CA
Curr Top Med Chem; 2013; 13(20):2562-80. PubMed ID: 24066891
[TBL] [Abstract][Full Text] [Related]
14. The path forward.
De Gregorio E
Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
[TBL] [Abstract][Full Text] [Related]
15. Combination of adjuvants: the future of vaccine design.
Mount A; Koernig S; Silva A; Drane D; Maraskovsky E; Morelli AB
Expert Rev Vaccines; 2013 Jul; 12(7):733-46. PubMed ID: 23885819
[TBL] [Abstract][Full Text] [Related]
16. 12th Annual Conference on Vaccine Research.
O'Brien J
Expert Rev Vaccines; 2009 Sep; 8(9):1139-42. PubMed ID: 19722886
[TBL] [Abstract][Full Text] [Related]
17. Vaccine adjuvants.
Reed SG
Expert Rev Vaccines; 2013 Jul; 12(7):705-6. PubMed ID: 23885812
[No Abstract] [Full Text] [Related]
18. IL-33 isoforms: their future as vaccine adjuvants?
Villarreal DO; Weiner DB
Expert Rev Vaccines; 2015 Apr; 14(4):489-92. PubMed ID: 25656504
[TBL] [Abstract][Full Text] [Related]
19. Vaccine adjuvant safety: the elephant in the room.
Petrovsky N
Expert Rev Vaccines; 2013 Jul; 12(7):715-7. PubMed ID: 23885815
[No Abstract] [Full Text] [Related]
20. Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.
Arakawa T
Expert Rev Vaccines; 2011 Jan; 10(1):1-5. PubMed ID: 21162613
[No Abstract] [Full Text] [Related]
[Next] [New Search]
